Insider Transactions Reported by 31 Insiders of Enliven Therapeutics, Inc.

Symbol
ELVN on Nasdaq
Location
Boulder, CO

Insiders trading volume in the past year

Enliven Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ORBIMED ADVISORS LLC Director, 10%+ Owner $169,666,547 16 May 2024
David P. Bonita Director, 10%+ Owner $63,552,894 02 Jun 2022
5AM Partners VI, LLC 10%+ Owner $57,156,028 14 Feb 2024
New Enterprise Associates 14, L.P. 10%+ Owner $39,518,242 05 Apr 2022
Mark Chin Director $35,477,530 02 Jun 2022
RA CAPITAL MANAGEMENT, L.P. Former 10% owner $32,123,508 23 Feb 2023
Braden M Leonard 10%+ Owner $30,236,309 03 Jan 2023
Barbara Dalton Director $23,576,122 02 Jun 2022
Commodore Capital LP 10%+ Owner $21,925,166 23 Feb 2023
Samuel Kintz PRESIDENT AND CEO, Director $19,427,552 -$2,100,217 -9.8% 17 Nov 2025
Joseph P. Lyssikatos Chief Scientific Officer $19,261,846 -$6,556,870 -25% 12 Feb 2026
CARL GOLDFISCHER Director $10,645,656 02 Jun 2022
Anish Patel Chief Operating Officer $5,964,579 -$2,508,807 -30% 12 Feb 2026
Richard A. Heyman Director $3,731,625 -$413,379 -10% 17 Feb 2026
DAVID M. MOTT Director $3,469,305 02 Jun 2022
Benjamin Hohl Chief Financial Officer $1,508,778 -$859,095 -36% 06 Mar 2026
Helen Louise Collins Chief Medical Officer $754,830 -$2,380,499 -76% 09 Mar 2026
Lori Anne Kunkel Director $710,829 12 Feb 2026
Kenneth Attie Svp, Cmo $516,104 28 Jan 2022
MICHAEL GRAY Cfo & Coo $417,877 22 Feb 2023
Andrew John Phillips Director 06 Feb 2025
Rishi Gupta Director 12 Feb 2026
Mika K. Derynck Director 12 Feb 2026
Andrew J. Schwab Director, 10%+ Owner 23 Feb 2023
Jake Bauer Director 12 Feb 2026
Rahul D. Ballal Director 12 Feb 2026
Richard A. Fair PRESIDENT AND CEO, Director 11 Dec 2025
J. Scott Garland Director 12 Feb 2026
Edward R. Conner Director 02 Jun 2022
Laura A. Williams Director 02 Jun 2022
Sara M. Nayeem Director 29 Jun 2021

Recent Insider Transactions by Companies or Individuals for Enliven Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Helen Louise Collins ELVN Common Stock Sale -28.8% $305,827 $30.19 -10,129 25,000 10 Mar 2026 Direct
Helen Louise Collins ELVN Common Stock Options Exercise 40.5% 10,129 35,129 10 Mar 2026 Direct
Helen Louise Collins ELVN Stock Option (right to buy) Options Exercise -5.29% -10,129 181,268 10 Mar 2026 Direct
Helen Louise Collins ELVN Common Stock Sale -54.4% $896,811 $30.02 -29,871 25,000 09 Mar 2026 Direct
Helen Louise Collins ELVN Common Stock Options Exercise 119.5% 29,871 54,871 09 Mar 2026 Direct
Helen Louise Collins ELVN Stock Option (right to buy) Options Exercise -13.5% -29,871 191,397 09 Mar 2026 Direct
Benjamin Hohl ELVN Common Stock Sale -16.4% $295,839 $29.58 -10,000 51,000 06 Mar 2026 Direct
Richard A. Heyman ELVN Common Stock Sale -5.15% $32,196 $26.18 -1,230 22,647 17 Feb 2026 See footnote
Helen Louise Collins ELVN Common Stock Sale -64.3% $1,177,862 $26.17 -45,000 25,000 17 Feb 2026 Direct
Helen Louise Collins ELVN Common Stock Options Exercise 180% 45,000 70,000 17 Feb 2026 Direct
Helen Louise Collins ELVN Stock Option (right to buy) Options Exercise -16.9% -45,000 221,268 17 Feb 2026 Direct
Lori Anne Kunkel ELVN Stock Option (right to buy) Award 17,126 17,126 12 Feb 2026 Direct
Richard A. Heyman ELVN Stock Option (right to buy) Award 19,234 19,234 12 Feb 2026 Direct
Rishi Gupta ELVN Stock Option (right to buy) Award 35,569 33,989 12 Feb 2026 Direct
J. Scott Garland ELVN Stock Option (right to buy) Award 1,427 1,427 12 Feb 2026 Direct
Mika K. Derynck ELVN Stock Option (right to buy) Award 17,126 17,126 12 Feb 2026 Direct
Jake Bauer ELVN Stock Option (right to buy) Award 17,126 17,126 12 Feb 2026 Direct
Rahul D. Ballal ELVN Stock Option (right to buy) Award 17,126 17,126 12 Feb 2026 Direct
Anish Patel ELVN Common Stock Award 20,000 20,000 12 Feb 2026 Direct
Anish Patel ELVN Stock Option (right to buy) Award 120,000 120,000 12 Feb 2026 Direct
Joseph P. Lyssikatos ELVN Common Stock Award 18,750 18,750 12 Feb 2026 Direct
Joseph P. Lyssikatos ELVN Stock Option (right to buy) Award 112,500 112,500 12 Feb 2026 Direct
Benjamin Hohl ELVN Common Stock Award 69.4% 25,000 61,000 12 Feb 2026 Direct
Benjamin Hohl ELVN Stock Option (right to buy) Award 150,000 150,000 12 Feb 2026 Direct
Helen Louise Collins ELVN Common Stock Award 25,000 25,000 12 Feb 2026 Direct
Helen Louise Collins ELVN Stock Option (right to buy) Award 150,000 150,000 12 Feb 2026 Direct
Joseph P. Lyssikatos ELVN Common Stock Sale -0.67% $145,219 $29.04 -5,000 740,188 06 Feb 2026 See footnote
Joseph P. Lyssikatos ELVN Common Stock Sale -2.61% $535,099 $26.75 -20,000 745,188 20 Jan 2026 See footnote
Richard A. Heyman ELVN Common Stock Sale -4.9% $32,902 $26.75 -1,230 23,877 20 Jan 2026 See footnote
Anish Patel ELVN Common Stock Sale -18.3% $1,351,762 $27.99 -48,300 215,011 09 Jan 2026 See footnote
Joseph P. Lyssikatos ELVN Common Stock Sale -10.6% $2,482,578 $27.22 -91,198 765,188 09 Jan 2026 See footnote
Richard A. Heyman ELVN Common Stock Sale -14.6% $107,125 $25.00 -4,285 25,107 09 Jan 2026 See footnote
Joseph P. Lyssikatos ELVN Common Stock Sale -4.6% $993,436 $24.05 -41,302 856,386 08 Jan 2026 See footnote
Richard A. Heyman ELVN Common Stock Sale -27.4% $241,156 $25.03 -9,635 25,545 08 Jan 2026 See footnote
J. Scott Garland ELVN Stock Option (right to buy) Award 59,372 59,372 07 Jan 2026 Direct
Benjamin Hohl ELVN Common Stock Options Exercise 56.5% 13,000 36,000 22 Dec 2025 Direct
Benjamin Hohl ELVN Stock Option (right to buy) Options Exercise -12.4% -13,000 92,056 22 Dec 2025 Direct
Joseph P. Lyssikatos ELVN Common Stock Sale -0.55% $84,206 $16.84 -5,000 897,688 19 Dec 2025 See footnote
Lori Anne Kunkel ELVN Common Stock Options Exercise 108.2% 15,958 30,712 17 Dec 2025 Direct
Lori Anne Kunkel ELVN Stock Option (right to buy) Options Exercise -81% -15,958 3,741 17 Dec 2025 Direct
Richard A. Fair ELVN Stock Option (right to buy) Award 875,000 875,000 11 Dec 2025 Direct
Anish Patel ELVN Common Stock Sale -2.47% $140,073 $21.02 -6,663 263,311 08 Dec 2025 See footnote
Joseph P. Lyssikatos ELVN Common Stock Sale -1.37% $279,155 $22.33 -12,500 902,688 19 Nov 2025 See footnote
Samuel Kintz ELVN Common Stock Sale -1.38% $272,739 $21.82 -12,500 890,392 17 Nov 2025 See footnote
Anish Patel ELVN Common Stock Sale -2.41% $116,034 $17.40 -6,667 269,974 07 Nov 2025 See footnote
Joseph P. Lyssikatos ELVN Common Stock Sale -1.35% $276,025 $22.08 -12,500 915,188 20 Oct 2025 See footnote
Samuel Kintz ELVN Common Stock Sale -1.37% $266,654 $21.33 -12,500 902,892 17 Oct 2025 See footnote
Anish Patel ELVN Common Stock Sale -2.35% $133,993 $20.10 -6,667 276,641 07 Oct 2025 See footnote
Benjamin Hohl ELVN Common Stock Sale -12.4% $66,291 $20.40 -3,250 23,000 29 Sep 2025 Direct
Benjamin Hohl ELVN Common Stock Options Exercise 14.1% 3,250 26,250 29 Sep 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.